Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Change in Cash: 2019-2024

Historic Change in Cash for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to -$252.6 million.

  • Maravai Lifesciences Holdings' Change in Cash fell 628.14% to -$26.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$334.6 million, marking a year-over-year decrease of 23006.56%. This contributed to the annual value of -$252.6 million for FY2024, which is 341.73% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Change in Cash of -$252.6 million as of FY2024, which was down 341.73% from -$57.2 million recorded in FY2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Change in Cash peaked at $315.1 million during FY2021, and registered a low of -$252.6 million during FY2024.
  • In the last 3 years, Maravai Lifesciences Holdings' Change in Cash had a median value of -$57.2 million in 2023 and averaged -$76.3 million.
  • In the last 5 years, Maravai Lifesciences Holdings' Change in Cash soared by 7,362.39% in 2020 and then tumbled by 341.73% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Change in Cash (Yearly) stood at $211.5 million in 2020, then skyrocketed by 48.99% to $315.1 million in 2021, then plummeted by 74.34% to $80.9 million in 2022, then tumbled by 170.70% to -$57.2 million in 2023, then slumped by 341.73% to -$252.6 million in 2024.